American Journal of Clinical Nutrition, Vol 49, 290-300, Copyright © 1989 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

alpha-Linolenic acid and long-chain omega-3 fatty acid supplementation in three patients with omega-3 fatty acid deficiency: effect on lymphocyte function, plasma and red cell lipids, and prostanoid formation

KS Bjerve, S Fischer, F Wammer and T Egeland
Department of Clinical Chemistry, Trondheim Regional Hospital, Norway.

alpha-Linolenic acid deficiency is described in three patients. Observed clinical symptoms were hemorrhagic dermatitis, hemorrhagic folliculitis, skin atrophy, and scaly dermatitis. Supplementation with ethyl alpha-linolenate followed by a purified fish oil (EPA-oil) began to normalize symptoms within 10 d. The mitogenic response in isolated lymphocytes was reduced whereas the number of T lymphocytes increased significantly. Serum thromboxanes, urinary excretion of 2,3-dinor-6- keto-prostaglandin F1 alpha (PGI2-M), and bleeding time were unaffected. The results indicate that omega-3 fatty acids are essential for normal accumulation of erythrocyte omega-6 acids. The dietary intake of long-chain omega-3 acids required to obtain midnormal concentrations of omega-3 acids in plasma and erythrocyte lipids was estimated to be 350-400 mg/d (0.4% of calories), whereas the corresponding mean intake of alpha-linolenic acid was 990 mg/d (1.0% of calories). It is suggested that essential fatty acid requirement should be stated as grams or milligrams per day, similarly to other essential nutrients.

This article has been cited by other articles:

				E. N Smit, E. A Oelen, E. Seerat, F. A J Muskiet, and E R. Boersma Breast milk docosahexaenoic acid (DHA) correlates with DHA status of malnourished infants Arch. Dis. Child., June 1, 2000; 82(6): 493 - 494. [Abstract] [Full Text]

				E. N Smit, E. A Oelen, E. Seerat, E R. Boersma, and F. A J Muskiet Fish oil supplementation improves docosahexaenoic acid status of malnourished infants Arch. Dis. Child., May 1, 2000; 82(5): 366 - 369. [Abstract] [Full Text]

				J. Eritsland Safety considerations of polyunsaturated fatty acids Am. J. Clinical Nutrition, January 1, 2000; 71(1): 197S - 201S. [Abstract] [Full Text] [PDF]